Qrons Announces Effectiveness of Its Post-Effective Amendment to Its Registration Statement

NEW YORK, NY / ACCESSWIRE / March 28, 2022 / Qrons Inc. (OTCQB:QRON), an innovative biotechnology company dedicated to developing next generation treatments for unmet neuronal diseases, using tissue engineering, stem cells and machine learning …